Wolfgang Miesbach: How Laboratory Strategies Must Evolve to Meet Expanding Haemophilia Therapies
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”An inspiring morning at EAHAD 2026 in Dublin: Annette Bowyer’s talk ‘Monitoring factor treatment in 2026 and beyond’ highlighted how rapidly our laboratory strategies must evolve to keep pace with the expanding spectrum of haemophilia therapies:
Monitoring needs to be tailored to the molecule and treatment class – from SHL/EHL/UHL concentrates to FVIII mimetics, gene therapy and emerging non‑factor therapies.
One‑stage and chromogenic assays each have strengths and limitations; for some products, results can be systematically over‑ or underestimated, demanding product‑specific approaches and clear lab–clinic communication.
Global assays of haemostasis and specific monitoring of FVIII mimetics and anti‑TFPI therapies are becoming increasingly important, but still require harmonisation and standardisation.
With more subcutaneous and non‑replacement options, the frequency and goals of monitoring are changing – from traditional peak/trough levels to efficacy, safety, inhibitor risk and transgene expression over the long term.
For haemophilia centres, this means closer collaboration between clinicians and specialised laboratories, investment in assay validation, and updated protocols to ensure safe, effective and personalised care in the era of innovative therapies.”
Stay updated with Hemostasis Today.
-
Sep 11, 2026, 16:31George Touma: Do We Really Need to Implant Metal in Every High-Bleeding-Risk Patient?
-
Sep 11, 2026, 16:24Yonah S. Tehrani: CDT vs Anticoagulation in Intermediate High Risk PE – The PRAGUE-26 Trial
-
Sep 11, 2026, 16:09Elad Anter։ A New Map of Atrial Fibrillation Initiation
-
Sep 11, 2026, 15:55Marwa Mostafa: The Paradox of Sideroblastic Anemia
-
Sep 11, 2026, 15:37Empowering Local Stakeholders to Advance Hemophilia Care in Côte d’Ivoire – World Federation of Hemophilia
-
Sep 11, 2026, 15:34Dhargam Aljebouri: A New Milestone for Transfusion Education in Iraq
-
Sep 11, 2026, 15:17Shadi Tabibian: Where Laboratory Precision Meets Clinical Care
-
Sep 11, 2026, 14:58Kevin Land: Connecting Donors to Patients Across the Spectrum of Care
-
Sep 11, 2026, 14:45Jorge Mascaro: The Growing Impact of the UK Aortic Society on Aortic Disease Care